Your browser doesn't support javascript.
loading
Usefulness of plasma full-length glypican-3 as a predictive marker of hepatocellular carcinoma recurrence after radial surgery.
Miura, Masahiro; Fujinami, Norihiro; Shimizu, Yasuhiro; Mizuno, Shoichi; Saito, Keigo; Suzuki, Toshihiro; Konishi, Masaru; Takahashi, Shinichiro; Gotohda, Naoto; Suto, Kouzou; Yoshida, Tomokazu; Nakatsura, Tetsuya.
Afiliação
  • Miura M; Central Research Laboratories, Sysmex Corporation, Kobe, Hyogo 651-2271, Japan.
  • Fujinami N; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba 277-8577, Japan.
  • Shimizu Y; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba 277-8577, Japan.
  • Mizuno S; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba 277-8577, Japan.
  • Saito K; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba 277-8577, Japan.
  • Suzuki T; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba 277-8577, Japan.
  • Konishi M; Division of Hepatobiliary Pancreatic Surgery, National Cancer Center Hospital East, Kashiwa, Chiba 277-8577, Japan.
  • Takahashi S; Division of Hepatobiliary Pancreatic Surgery, National Cancer Center Hospital East, Kashiwa, Chiba 277-8577, Japan.
  • Gotohda N; Division of Hepatobiliary Pancreatic Surgery, National Cancer Center Hospital East, Kashiwa, Chiba 277-8577, Japan.
  • Suto K; Central Research Laboratories, Sysmex Corporation, Kobe, Hyogo 651-2271, Japan.
  • Yoshida T; Central Research Laboratories, Sysmex Corporation, Kobe, Hyogo 651-2271, Japan.
  • Nakatsura T; Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba 277-8577, Japan.
Oncol Lett ; 19(4): 2657-2666, 2020 Apr.
Article em En | MEDLINE | ID: mdl-32218816
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article